Prevention of Smoking Related Diseases
LSP-3
Integrated Primary and Secondary Prevention of Smoking Related Diseases With Low Dose CT Scan and Circulating Biomarkers, Coupled With Personalised Smoking Cessation Activity
1 other identifier
observational
189
1 country
1
Brief Summary
This is a prospective, observational, monocentric study. This study wants to test if among a smoking cessation intervention, behavioural counselling by video session is related to higher compliance and higher success rate than standard smoking cessation activity (face to face counselling).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 11, 2022
CompletedFirst Submitted
Initial submission to the registry
May 30, 2024
CompletedFirst Posted
Study publicly available on registry
June 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedNovember 29, 2024
November 1, 2024
4 years
May 30, 2024
November 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Create an innovative smoking cessation program with personalized and tailored primary prevention support within screening programs.
The study aims to evaluate the difference in success between standard anti-smoking psychological counselling, conducted through face-to-face interviews, and anti-smoking psychological counselling conducted through remote video interviews.
from enrollment to the end treatment at 1 year
Study Arms (2)
face-to-face interviews
The group that will carry out the psychological counselling in the presence will have 6 meetings (spread over 6 months) with a psychologist at the anti-smoking center in the hospital and a final phone call 12 months after the first meeting to verify the maintenance of abstinence.
video interviews
The group that will be followed in remote mode will carry out the same number of interviews as the group described above and a 12-months call will also be made to them to check the state of abstinence.
Eligibility Criteria
Strong smokers enrolled in the lung cancer screening program.
You may qualify if:
- Strong smokers (pack years \>= 20)
- Over or equal the age of 50
- Able to sign specific informed consent for the study
You may not qualify if:
- Not having plans to quit smoking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Scientific Institute Ospedale San Raffaele
Milan, Italy, Milan, 20132, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
May 30, 2024
First Posted
June 10, 2024
Study Start
January 11, 2022
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
November 29, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share